TRPM2, TFEB and LAL: A New Link

TRPM2, TFEB and LAL: A New Link

New Research Identifies a Pathway Regulating Lysosomal Acid Lipase (LAL) Activity and Lysosomal Health Research into lysosomal diseases continues to advance, providing new insights into the cellular mechanisms that maintain metabolic balance. A recent study published...
The Importance of Early Diagnosis in Wolman Disease

The Importance of Early Diagnosis in Wolman Disease

  New Publication Expands Knowledge of Wolman Disease and Reports a Novel LIPA Variant A recent article published in Frontiers in Pediatrics reports on two Chinese infants diagnosed with Wolman Disease, the most severe infantile form of Lysosomal Acid Lipase...
Research and Hope for LAL-D

Research and Hope for LAL-D

  New Research Project Explores Innovative Strategies for Lysosomal Acid Lipase Deficiency (LAL-D) At LAL-D Patient Organization, we would like to congratulate Matthias Zadory on the successful defense of his doctoral thesis, “Engineering Non-Viral Gene...
New Findings from the International LAL-D Registry

New Findings from the International LAL-D Registry

  New International LAL-D Registry Study Shows Sustained Improvements in Lipid Profiles with Sebelipase Alfa Treatment   A new study published in Atherosclerosis provides important long-term evidence on the impact of sebelipase alfa enzyme replacement...
University of Rochester – Phase 4 Study

University of Rochester – Phase 4 Study

University of Rochester Seeks Participants for Final Validation Study of a New Lysosomal Acid Lipase Deficiency (LAL-D) Assessment Tool The University of Rochester (United States) is conducting the final phase of a research study aimed at developing and validating the...